Esperance is a medical technologies company founded in 2023 by Amy Johns. Amy’s unwavering mission is to optimize the health and quality of life for everyone, both on Earth and in space. The Esperance Team is composed of multidisciplinary experts, graduates and undergraduates who collaborate with NASA and other partners to design, test, and implement Amy’s original new medical technology, The Automated Medical Yeoman (AMY).
Esperance was established to begin the development of the AMY for the benefit of humanity. The team enjoys interacting with public and private entities to bring our technological revolution to the forefront of healthcare. At Esperance, our labor of love is driven by the belief that what is wanted can be had, and that events will turn out for the best.